Featured Research

from universities, journals, and other organizations

Synthesized sponge chemical shows promise for cancer

Date:
February 7, 2014
Source:
RMIT University
Summary:
A promising compound for cancer treatment has been synthesized in a laboratory by a PhD student.

A promising compound for cancer treatment has been synthesized in a laboratory by an RMIT University researcher during his PhD research.

Dr Dan Balan, from the School of Applied Sciences at RMIT, said 15-aza-Salicylihalamide A analogue had demonstrated potent activity against several leukemia cell lines.

"Salicylihalamide A is an interesting natural marine product that has been isolated from a marine sponge of the genus Haliclona, collected from waters around Rottnest Island, 18 km off the coast of southern Western Australia," Dr Balan said.

Salicylihalamide A is cytotoxic -- or a toxin which is known to destroy cells and which also provides a defense for the sea sponge.

"My goal was to synthesise the chemical in the laboratory in the form of a single aza-salicylihalamide A analogue molecule," he said.

The aza-salicylihalamide A analogue molecules were then exposed to NCI-60 leukemia cell lines, and exhibited antiproliferating effects on the group of cells at highly diluted, or 'sub-molar', concentrations.

"15-aza-Salicylihalamide A Analogue has proven to be very active against various types of cancer, but it was clearly most active against HL-60, which is acute promyelocytic leukemia," he said.

Other findings revealed it to be an inhibitor of vacuolar ATPase and proton pumps, frequently found in metastatic cancer cells -- which are cancer cells that have migrated through the bloodstream from more advanced tumours.

"The molecule was synthesized in a short molecular sequence that could be easily produced in very large volumes for drug production," Dr Balan said.

He explained there will be further research to investigate its effectiveness on different cancers, potentially leading to extensive drug development.


Story Source:

The above story is based on materials provided by RMIT University. Note: Materials may be edited for content and length.


Cite This Page:

RMIT University. "Synthesized sponge chemical shows promise for cancer." ScienceDaily. ScienceDaily, 7 February 2014. <www.sciencedaily.com/releases/2014/02/140207083727.htm>.
RMIT University. (2014, February 7). Synthesized sponge chemical shows promise for cancer. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/02/140207083727.htm
RMIT University. "Synthesized sponge chemical shows promise for cancer." ScienceDaily. www.sciencedaily.com/releases/2014/02/140207083727.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins